DEDICAID
LIVE

Serial Number

79384529

Owner

Telix Pharmaceuticals Limited

Attorney

Andrew S. Ehard

Filing Date

Oct 26, 2023

Add to watchlist:

No watchlists yet
View on USPTO

DEDICAID Trademark

Serial Number: 79384529 • Registration: 7813370

DEDICAID is a trademark filed by Telix Pharmaceuticals Limited on October 26, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Telix Pharmaceuticals Limited (38 trademarks)

Suite 401, 55 Flemington Road

Entity Type: 99

Trademark Details

Filing Date

October 26, 2023

Registration Date

June 3, 2025

Published for Opposition

April 15, 2025

Goods & Services

Medical analysis services for the diagnosis and treatment of persons experiencing health concerns; Medical analysis services relating to the treatment of persons; Medical diagnostic services; Medical health assessment services; Services for the preparation of medical reports, namely, providing medical information to patients, in the form of reports in the field of health and wellness; Advisory services relating to medical services; Consultancy and advisory services in relation to medical services; Provision of medical information; Consulting services in the field of healthcare; Health screening services in the field of cancer to assess overall patient health and wellness; Information services relating to health care in the nature of providing healthcare information; Preparation of reports relating to health care matters for medical purposes

Software as a service (SAAS) services featuring software for analyzing potential outcomes to support clinical decision-making in health services, identifying clinical trial efficiencies and predicting health outcomes; Computer software design; Computer software development; Computer software programming services for others in the field of healthcare; Development of software for predicting health outcomes; Software as a service (SAAS) services, namely, hosting software for use by others for analyzing potential outcomes to support clinical decision-making in health services, identifying clinical trial efficiencies and predicting health outcomes; Installation of computer software; Software creation in the nature of computer software design; Software engineering services; Design and writing of computer software; Online provision of web-based applications, namely, providing temporary use of on-line web-based decentralized non-downloadable applications for analyzing potential outcomes to support clinical decision-making in health services, identifying clinical trial efficiencies and predicting health outcomes; Online provision of web-based software, namely providing temporary use of online non-downloadable software for analyzing potential outcomes to support clinical decision-making in health services, identifying clinical trial efficiencies and predicting health outcomes

Downloadable computer operating software; Downloadable computer application software for computers, namely, software for analyzing potential outcomes to support clinical decision-making in health services, identifying clinical trial efficiencies and predicting health outcomes; Downloadable computer operating programs for medical purposes; Downloadable computer operating programs for medical data analysis; Downloadable computer operating software for medical data analysis; Downloadable computer software using artificial intelligence software for use in software development; Downloadable software for applying artificial intelligence programs in consumer web-based services and products; Downloadable computer software using artificial intelligence for analyzing potential outcomes to support clinical decision-making in health services, identifying clinical trial efficiencies and predicting health outcomes

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 29, 2026 FINO
NEW REPRESENTATIVE AT IB RECEIVED
Jan 22, 2026 NREP
FINAL DISPOSITION NOTICE SENT TO IB
Jan 2, 2026 FICS
FINAL DISPOSITION PROCESSED
Jan 2, 2026 FIMP
NEW REPRESENTATIVE AT IB RECEIVED
Jan 1, 2026 NREP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 3, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 3, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 3, 2025 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 24, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 6, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 6, 2025 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 15, 2025 NPUB
PUBLISHED FOR OPPOSITION
Apr 15, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 9, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 17, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 17, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 17, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 17, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 17, 2025 CNEA
EXAMINER'S AMENDMENT ENTERED
Mar 11, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 11, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 11, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 11, 2025 CNEA
EXAMINER'S AMENDMENT ENTERED
Feb 11, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 11, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 11, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 11, 2025 CNEA
ASSIGNED TO EXAMINER
Jan 26, 2025 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 2, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 2, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 2, 2024 TROA
REFUSAL PROCESSED BY IB
Apr 30, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 6, 2024 RFCS
REFUSAL PROCESSED BY MPU
Apr 6, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 19, 2024 RFCR
NON-FINAL ACTION WRITTEN
Mar 18, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 14, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 12, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 8, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 7, 2023 REPR